Melmed Gil Y, Siegel Corey A
Dr. Melmed is a Clinical Assistant Professor of Medicine in the Division of Gastroenterology in the Department of Medicine at Cedars-Sinai Medical Center in Los Angeles, California. Dr. Siegel is an Associate Professor of Medicine in the Section of Gastroenterology and Hepatology in the Department of Medicine at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire.
Gastroenterol Hepatol (N Y). 2013 May;9(5):286-92.
Chronic illnesses such as inflammatory bowel disease (IBD) present a unique opportunity to define and improve the quality of care. Processes of care can be complex, and outcomes of care may vary across different healthcare delivery settings. Patients with IBD are managed over long periods of time and often by the same physician within a single care delivery system. Both patients with Crohn's disease and ulcerative colitis have variable courses of disease progression that require changes in therapy over time. These factors necessitate multiple areas of potential assessment and improvement of processes and outcomes of care. A current initiative is the development of quality measures. The American Gastroenterological Association has developed accountability measures for the Physician Quality Reporting System, and the Crohn's and Colitis Foundation of America has developed a set of top 10 recommended processes and outcomes of measurement for high-quality care of patients with IBD. In addition, the pediatric ImproveCareNow collaborative network has collected improvement data from dozens of pediatric centers over the past 5 years and has demonstrated improvement in overall disease activity in their cohort through iterative quality improvement processes. Future directions for quality indicators for adults with IBD will involve implementation of quality-measure reporting, both for purposes of reimbursement as well as improvement of care. These strategies will need to be closely monitored to evaluate the effect of improvement programs on outcomes.
诸如炎症性肠病(IBD)之类的慢性病为界定和提高医疗质量提供了独特的契机。医疗过程可能很复杂,而且不同医疗服务提供机构的医疗结果也可能存在差异。IBD患者需要长期接受治疗,并且通常由单一医疗服务系统中的同一位医生负责。克罗恩病和溃疡性结肠炎患者的疾病进展过程各不相同,这就需要随着时间的推移调整治疗方案。这些因素使得有必要在多个领域对医疗过程和结果进行潜在评估并加以改进。当前的一项举措是制定质量指标。美国胃肠病学会已经为医师质量报告系统制定了问责指标,美国克罗恩病和结肠炎基金会也已制定了一套针对IBD患者高质量医疗的十大推荐医疗过程及测量结果。此外,儿科改善医疗现状协作网络在过去5年里收集了数十家儿科中心的改进数据,并通过反复的质量改进过程,证明其队列中的总体疾病活动状况有所改善。IBD成年患者质量指标的未来发展方向将包括实施质量指标报告,其目的既是为了报销,也是为了改善医疗。需要密切监测这些策略,以评估改进计划对医疗结果的影响。